L923-0626 Screening compound: N-({1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}methyl)-4-(3-methyl-1,2-oxazol-5-yl)thiophene-2-sulfonamide

L923-0626 Screening compound: N-({1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}methyl)-4-(3-methyl-1,2-oxazol-5-yl)thiophene-2-sulfonamide
L923-0626 Screening compound: N-({1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}methyl)-4-(3-methyl-1,2-oxazol-5-yl)thiophene-2-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L923-0626
N-({1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}methyl)-4-(3-methyl-1,2-oxazol-5-yl)thiophene-2-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L923-0626

Molecular Formula

C23H29N3O4S2 (C23 H29 N3 O4 S2)

Compound Name

N-({1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}methyl)-4-(3-methyl-1,2-oxazol-5-yl)thiophene-2-sulfonamide

IUPAC name

N-({1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}methyl)-4-(3-methyl-12-oxazol-5-yl)thiophene-2-sulfonamide

SMILES

Cc1noc(-c2csc(S(NCC3CCN(CCc(cc4)ccc4OC)CC3)(=O)=O)c2)c1

InChI

InChI=1S/C23H29N3O4S2/c1-17-13-22(30-25-17)20-14-23(31-16-20)32(27,28)24-15-19-8-11-26(12-9-19)10-7-18-3-5-21(29-2)6-4-18/h3-6,13-14,16,19,24H,7-12,15H2,1-2H3

InChI Key

HQUFCVCKJRHTOC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27487038

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

475.63

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.152

Distribution Coefficient, logD

2.097

Water Solubility, LogSw

-4.14

Polar Surface Area

75.612

Acid Dissociation Constant (pKa)

10.63

Base Dissociation Constant (pKb)

9.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

43.50

L923-0626 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L923-0626 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L923-0626?
Check Price and Availability of L923-0626, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L923-0626 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L923-0626
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L923-0626
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L923-0626 available by request